The leading corneal research presented at ASCRS offered a glimpse at the subspecialty’s most promising medical and surgical advancements.

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care ...

The department of biochemistry, Father Muller Medical College, Kankanady, hosted the inauguration of the 10th annual state ...

Century Therapeutics, Inc. (NASDAQ: IPSC) has announced its participation in the upcoming European Alliance of Associations ...

Fulcrum Therapeutics, Inc.® (the “Company”) (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with genetically defined ...

WJAC provides news, weather and sports information for Johnstown, Altoona, State College and DuBois, Pennsylvania. Our ...

Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel radioimmunotherapy and ...